StreetAlpha.app
Home › Stocks › BDX

Becton Dickinson & Co (BDX)

Healthcare
$215.47
▼ −0.48%
LAST CLOSE · NOV 17

Becton Dickinson makes medical devices and clinical diagnostic products for hospitals, researchers and other healthcare customers. It last closed at $215.47 on Nov 17, down 0.48% on the day. BDX reports earnings on Mon, Feb 8, 2027. The average 12-month price target from 8 analysts is $216.88 (+0.7% from the last close), with a high of $242.00 and a low of $195.00. Analyst consensus is Hold, based on the latest ratings from 8 firms (3 buy, 4 hold, 1 sell). Over the past 90 days StreetAlpha recorded 1 whale options trade in BDX, 0% of them bullish and 100% bearish. In the past 30 days there were 10 dark pool prints totaling $13.1M, the largest $3.2M.

AI Auto Pilots
Is BDX in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$22.5B
+18.5% vs a year ago
Net income
$942.0M
−40.6% vs a year ago
EPS (diluted)
$3.31
−39.5% vs a year ago
Gross margin
46.9%
$10.6B gross profit
Valuation
Market cap
$58.7B
272.4M shares
P/E
65.1
Price over 12 month EPS
Price to sales
2.6
Market cap over revenue
Dividend yield
1.94%
$4.19 a share over 12 months
Balance sheet
Cash & equivalents
$708.0M
At Jun 30
Debt
$16.8B
At Jun 30
Shareholder equity
$24.4B
Buybacks
$2.5B
Last 12 months
Fiscal year endsSeptember
ExchangeNYSE
Financials history
FY2021: $19.1B$19.1BFY2021FY2022: $18.9B$18.9BFY2022FY2023: $19.4B$19.4BFY2023FY2024: $20.2B$20.2BFY2024FY2025: $21.8B$21.8BFY2025

From BDX's SEC filings, latest 10-Q for the period ending Jun 30, 2026 (filed Aug 6). Last 12 months adds up the four latest quarters.

Next report
Feb 8
2027 · Time not announced
Consensus EPS forecast
$2.35
$4.50B revenue est.
Year-ago EPS
—
Not on file
Options-implied move
—
Posted about a week before
Analyst consensus
Hold
Based on 8 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Hold
8firms
3 Buy4 Hold1 Sell
Each firm's latest rating on BDX in the past 90 days
Average 12-month target
$216.88
▲ 0.7% upside

Based on 8 analysts who set a price target on BDX in the past 90 days. The average target is $216.88, with a high of $242.00 and a low of $195.00, compared with the last close of $215.47.

Low $195.00Avg $216.88High $242.00
Blue marker: last close $215.47
Highest target$242.00
Average target$216.88
Lowest target$195.00
Latest rating changes
BarclaysTarget raised
Nov 10Sell$165 → $195
JP MorganMaintained
Nov 7Hold$202
CitigroupTarget raised
Nov 6Buy$204 → $241
RBC CapitalTarget raised
Nov 6Hold$190 → $225
Evercore ISI GroupTarget raised
Nov 6Buy$180 → $230
DateFirmActionRatingPrice target
Nov 10BarclaysTarget raisedSell$165 → $195
Nov 7JP MorganMaintainedHold$202
Nov 6CitigroupTarget raisedBuy$204 → $241
Nov 6RBC CapitalTarget raisedHold$190 → $225
Nov 6Evercore ISI GroupTarget raisedBuy$180 → $230
Loading…

Technical Analysis

BDX · as of the Nov 17 close · updated after every close
Uptrend, nearing overbought

The stock is 4% above its 20 day and 11% above its 50 day average. It is 22% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 70), near overbought. The nearest support is the Pivot S1 at $214.02, and the nearest resistance the Pivot at $215.50.

Short trendBullish
Long trendBullish
MomentumStrong
StretchNear overbought
VolatilityNormal, 2.1%/day
Key levels
$220.3652 week high+2.3%
$216.95Pivot R1+0.7%
$215.50Pivot+0.0%
$215.47Last close
$214.02Pivot S1−0.7%
$209.00Swing low (Nov 11)−3.0%
$205.7920 day average−4.5%
$192.2950 day average−10.8%
$181.38100 day average−15.8%
$169.05200 day average−21.5%
$140.1152 week low−35.0%
Indicators
RSI (14)69.73Strong, overbought above 70Neutral
MACD7.39Above its signal lineBullish
Stochastic86.7Near the top of its rangeOverbought
ADX (14)51.7Strong uptrend
Williams %R-18.9Oversold below −80, overbought above −20Overbought
CCI (20)80.7Oversold below −100, overbought above 100Neutral
Rate of change+8.8%Change over 10 sessionsBullish
ATR (14)$4.46Typical daily range, 2.1% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for BDX

What happened before

See how BDX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow BDX usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How BDX has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Total alerts
1
Bullish
0
0%
Bearish
1
100%
Date span
Nov 6 – Nov 6
Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
10
Notional
$13.1M
Largest print
$3.2M
Loading…

BDX Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●655 buying vs 680 selling
  • ▼Held by funds -8.7 pts
  • ▲Funds holding +50
  • ▲Superinvestors: 3 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding1,4931,443+3.5%
In funds' top 10149+55.6%
Held by funds93.7%102.3%−8.7 pts
New / increased164 / 491119 / 541−0.8%
Reduced / sold out579 / 101546 / 152−2.6%
Put/call ratio2.200.62+252.9%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See BDX institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

BDX Stock Buybacks

See all S&P 500 buybacks →
Spent, 12 months
$2.5B
4.3% yield
Left in program
8.3M sh
3.0% of shares
Shares outstanding, 12 months
−5.0%
Fewer shares
Last quarter
$400.4M
Jun 2026
Avg price paid, last quarter
$124.58
3.2M shares bought
S&P 500 rank by spending
#91 of 358
 
Spent each quarter, last 3 yearsTop bar $1.6B
Sep 2023: $618K, average price $269.45Dec 2023: $500.3M, average price $236.06Mar 2024: $365K, average price $238.27Jun 2024: $359K, average price $233.20Sep 2024: $338K, average price $239.07Dec 2024: $607.7M, average price $230.36Mar 2025: $143.0M, average price $230.38Jun 2025: $286K, average price $198.59Sep 2025: $250.4M, average price $195.66Dec 2025: $250.3M, average price $190.06Mar 2026: $1.6B, average price $171.68Jun 2026: $400.4M, average price $124.58
Sep 2023Jun 2026
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.

From the company's 10-Q filed Aug 6, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether BDX is in one of them and how their past BDX trades turned out.

BDX in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered BDX in an article yet. Here's the latest on the wider market.

BDX Congress Trades

All congress trades →
Trades, 12 months
14
Buys
7
50%
Sells
7
50%
People
6
Last filed Oct 7
Who traded BDX · since 2016
Latest 5 filings of 116
$1K – $15KTraded Sep 11, 2026Filed Oct 7, 2026
$100K – $250KTraded Jul 31, 2026Filed Sep 22, 2026
$1K – $15KTraded Mar 27, 2026Filed Jul 21, 2026
$1K – $15KTraded Jun 2, 2026Filed Jul 6, 2026
$1K – $15KTraded May 21, 2026Filed Jun 18, 2026
PersonTypeAmountTradedFiledDelay
Ro KhannaD · CABuy$1K – $15KSep 11, 2026Oct 7, 202626 d
Donald J TrumpExecutive branchBuy$100K – $250KJul 31, 2026Sep 22, 202653 d
Alan ArmstrongHouseBuy$1K – $15KMar 27, 2026Jul 21, 2026116 d
Ro KhannaD · CASell$1K – $15KJun 2, 2026Jul 6, 202634 d
Thomas KeanR · NJSell$1K – $15KMay 21, 2026Jun 18, 202628 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Becton Dickinson &

Becton Dickinson is a medical technology company based in Franklin Lakes, New Jersey. It makes medical devices and clinical diagnostic products used in healthcare settings. Its customers include hospitals and other healthcare providers, as well as pharmaceutical and biotechnology companies, academic institutions, government laboratories and private foundations that buy its products for research. A substantial part of its revenue comes from outside the United States.

Headquarters
Franklin Lakes, NJ
Founded
1897
Website
bd.com ↗